Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial
ConclusionsThe clinically beneficial, single nighttime dose of ON-SXB significantly improved disrupted nighttime sleep in patients with narcolepsy.Clinical Trial RegistrationClinicalTrials.gov NCT02720744.
Source: CNS Drugs - Category: Neurology Source Type: research
More News: Clinical Trials | Narcolepsy | Neurology | Sleep Disorders | Sleep Medicine | Sodium | Statistics